Production (Stage)
Universal Ibogaine Inc.
IBO.V
TSX
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 92.67% | -30.13% | -65.84% | -175.00% | -76.87% |
| Total Depreciation and Amortization | -4.55% | 3.47% | -4.54% | 7.89% | 11.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -98.61% | -83.59% | -44.12% | 441.94% | 762.58% |
| Change in Net Operating Assets | -35.61% | -81.57% | 116.67% | -287.04% | -145.85% |
| Cash from Operations | 78.97% | -181.35% | -32.62% | -1,541.86% | -190.64% |
| Capital Expenditure | -- | -- | 96.43% | -12.60% | 55.06% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 96.43% | -12.60% | 55.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.61% | 0.93% | 16.45% | -326.57% | -697.56% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 98.95% | 13,093.75% | -- | -- | -- |
| Cash from Financing | -105.48% | 29.42% | -151.54% | 117.76% | 66.21% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -232.26% | -15.38% | -81.12% | -143.29% | -34.57% |